LENSAR Inc (NASDAQ:LNSR) — Market Cap & Net Worth
Market Cap & Net Worth: LENSAR Inc (LNSR)
LENSAR Inc (NASDAQ:LNSR) has a market capitalization of $67.01 Million ($67.01 Million) as of May 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #20740 globally and #4460 in its home market, demonstrating a 6.65% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LENSAR Inc's stock price $5.61 by its total outstanding shares 11944546 (11.94 Million). Analyse LNSR cash generation efficiency to see how efficiently the company converts income to cash.
LENSAR Inc Market Cap History: 2020 to 2026
LENSAR Inc's market capitalization history from 2020 to 2026. Data shows change from $86.60 Million to $67.01 Million (-8.12% CAGR).
Index Memberships
LENSAR Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.00% | #596 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.00% | #2008 of 3165 |
Weight: LENSAR Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
LENSAR Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LENSAR Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.00x
LENSAR Inc's market cap is 2.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $86.60 Million | $26.38 Million | -$19.77 Million | 3.28x | N/A |
| 2021 | $71.55 Million | $34.46 Million | -$19.60 Million | 2.08x | N/A |
| 2022 | $35.36 Million | $35.36 Million | -$19.91 Million | 1.00x | N/A |
| 2023 | $41.93 Million | $42.16 Million | -$14.38 Million | 0.99x | N/A |
| 2024 | $106.78 Million | $53.49 Million | -$31.40 Million | 2.00x | N/A |
Competitor Companies of LNSR by Market Capitalization
Companies near LENSAR Inc in the global market cap rankings as of May 3, 2026.
Key companies related to LENSAR Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
LENSAR Inc Historical Marketcap From 2020 to 2026
Between 2020 and today, LENSAR Inc's market cap moved from $86.60 Million to $ 67.01 Million, with a yearly change of -8.12%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $67.01 Million | -51.76% |
| 2025 | $138.92 Million | +30.09% |
| 2024 | $106.78 Million | +154.70% |
| 2023 | $41.93 Million | +18.58% |
| 2022 | $35.36 Million | -50.58% |
| 2021 | $71.55 Million | -17.38% |
| 2020 | $86.60 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of LENSAR Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $67.01 Million USD |
| MoneyControl | $67.01 Million USD |
| MarketWatch | $67.01 Million USD |
| marketcap.company | $67.01 Million USD |
| Reuters | $67.01 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About LENSAR Inc
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcom… Read more